InvestSMART

MedAdvisor Limited (ASX:MDR)

ALERT: Price-sensitive ASX Announcement for MDR
Current share price for MDR : $0.022 -0.034 (-60.71%)+
Announcement
Release
29 Aug 2025 9:47AM
Price at Release
$0.056
Full Release
download
Summary
MedAdvisor Limited's Appendix 4E Preliminary Final Report for the financial year ending 30 June 2025 reveals significant financial challenges. The company reported a substantial loss after tax from continuing operations amounting to $63.3 million, compared to a smaller loss the previous year. However, there was a profit from discontinuing operations. Total revenue from continuing operations decreased significantly from the previous year to $62.9 million. The report highlights substantial impairment of assets, increased financial charges, and a decrease in total equity. Despite these challenges, MedAdvisor completed the sale of its ANZ business post the reporting period, which significantly reduced its debt. The financial statements are in the process of being audited.
Key Points
  • MedAdvisor Limited incurred a significant loss from continuing operations at $63.3 million.
  • Revenue from continuing operations dropped to $62.9 million.
  • Profit from discontinuing operations was recorded.
  • Significant impairment of assets noted.
  • Decrease in total equity to a deficit position.
  • Post reporting period sale of ANZ business reducing debt.
  • Financial statements are under audit.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.